Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gardasil Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06624839
What this trial is testing

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Who this might be right for
Human Papilloma VirusAnal DysplasiaHIV
University of Maryland, Baltimore 120
Not applicableEnded earlyNCT01355003
What this trial is testing

GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,080
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Post-approval studies (Phase 4)Study completedNCT06345885
What this trial is testing

Immunogenicity and Safety of One Dose of HPV Vaccine

Who this might be right for
Human Papillomavirus Vaccines
Xiamen Innovax Biotech Co., Ltd 200
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Large-scale testing (Phase 3)UnknownNCT01512784
What this trial is testing

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

Who this might be right for
HPVHIV
University of Milan 100
Large-scale testing (Phase 3)Study completedNCT00092547
What this trial is testing

Gardasil (V501) in Preadolescents and Adolescents (V501-018)

Who this might be right for
HumanPapillomavirus Infections
Merck Sharp & Dohme LLC 1,781
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756840
What this trial is testing

Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

Who this might be right for
Respiratory Recurrent Papillomatosis (RRP)Human Papillomavirus (HPV)Papillomavirus Infection+3 more
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Study completedNCT03546842
What this trial is testing

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Who this might be right for
Papillomavirus InfectionsUterine Cervical NeoplasmsVulvar Neoplasms+3 more
Merck Sharp & Dohme LLC 201
Post-approval studies (Phase 4)Looking for participantsNCT05672927
What this trial is testing

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

Who this might be right for
ImmunizationHPV InfectionHuman Papillomavirus
The University of Texas Medical Branch, Galveston 618
Early research (Phase 1)Study completedNCT01741012
What this trial is testing

Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
Wayne State University 37
Not applicableStudy completedNCT01077856
What this trial is testing

GARDASIL™ Vaccine Impact in Population Study (V501-033)

Who this might be right for
Human Papillomavirus Infections
Merck Sharp & Dohme LLC 54,516
Testing effectiveness (Phase 2)Study completedNCT00520598
What this trial is testing

Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 511
Large-scale testing (Phase 3)Study completedNCT01462357
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,079
Large-scale testing (Phase 3)Study completedNCT01456715
What this trial is testing

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Who this might be right for
Human Papillomavirus
Laval University 418
Testing effectiveness (Phase 2)Study completedNCT00551187
What this trial is testing

Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 620
Large-scale testing (Phase 3)Study completedNCT03728881
What this trial is testing

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Who this might be right for
Human Papillomavirus-Related Cervical Carcinoma
National Cancer Institute (NCI) 1,240
Large-scale testing (Phase 3)Study completedNCT00090220
What this trial is testing

Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)

Who this might be right for
Healthy Adult Female ParticipantsPreventionPapillomavirus Infection+1 more
Merck Sharp & Dohme LLC 3,819
Post-approval studies (Phase 4)Study completedNCT01544478
What this trial is testing

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

Who this might be right for
Cervical CancerCervical Intraepithelial NeoplasiaAdenocarcinoma in Situ
Merck Sharp & Dohme LLC 1,030
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464
What this trial is testing

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Who this might be right for
Idiopathic CD4 T Cell Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 54
Next Page